Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells (Q80590474)
Jump to navigation
Jump to search
scientific article published on 01 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells |
scientific article published on 01 December 2007 |
Statements
Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells (English)
Jennifer Kaplan
James A Cook
Michael O'Connor
Basilia Zingarelli